Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Sera Prognostics (SERA) Research & Development (2020 - 2026)

Sera Prognostics filings provide 6 years of Research & Development readings, the most recent being $3.2 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 2.45% to $3.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.2 million, a 10.58% decrease, with the full-year FY2025 number at $13.2 million, down 10.58% from a year prior.
  • Research & Development hit $3.2 million in Q4 2025 for Sera Prognostics, down from $3.3 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $4.4 million in Q2 2024 to a low of $2.4 million in Q1 2021.
  • Median Research & Development over the past 5 years was $3.3 million (2025), compared with a mean of $3.4 million.
  • Biggest five-year swings in Research & Development: surged 61.19% in 2021 and later decreased 24.26% in 2025.
  • Sera Prognostics' Research & Development stood at $3.1 million in 2021, then increased by 13.33% to $3.5 million in 2022, then rose by 11.76% to $3.9 million in 2023, then fell by 19.41% to $3.1 million in 2024, then grew by 2.45% to $3.2 million in 2025.
  • The last three reported values for Research & Development were $3.2 million (Q4 2025), $3.3 million (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.